Gastrointestinal manifestations associated with COVID-19

Manifestaciones gastrointestinales asociadas al COVID-19

• Edgardo Mengual-Moreno Universidad del Zulia https://orcid.org/0000-0002-9872-5186
• Maribel Lizarzábal-García Universidad del Zulia http://orcid.org/0000-0002-6185-5163

Keywords: SARS-COV-2, COVID-19, vaccines

Abstract

The SARS-CoV-2 is responsible for the COVID-19 that has affected millions of people and deaths in the world, needed urgent vaccine for the entire population. In this regard, modern technology has allowed effective vaccine developed in different parts of the world such as the United States, Germany, United Kingdom, China, among others; to control the COVID-19 pandemic. In this review the characteristics of the vaccines reached phase III studies and are currently being applied in immunization schedules in the world population against COVID-19 detailing. There are doubts whether these vaccines created in record time produce permanent immunity or protection against mutations of the SARS-CoV-2 and long-term adverse effects.

References

Cha M, Regueiro M, Sandhu DS. Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review. World J Gastroenterol 2020;26(19):2323-2332.

Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, y cols. Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study. Am J Gastroenterol 2020;115(5):766-773.

Mao R, Qiu Y, He J, Tan J, Li X, Liang J, Shen J, y cols. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(7):667-678.

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, y cols; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;382(18):1708-1720.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, y cols. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497-506.

Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, y cols; COVID-19 Lombardy ICU Network. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574-1581.

Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L, y cols. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis 2020;71(15):889-890.

Mao R, Qiu Y, He J, Tan J, Li X, Liang J, y cols. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(7):667-678.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, y cols. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020;323(11):1061-1069.

Jin X, Lian J, Hu J, Gao J, Zheng L, Zhang Y, y cols. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 2020;69(6):1002-1009.

Wang F, Wang H, Fan J, Zhang Y, Wang H, Zhao Q. Pancreatic Injury Patterns in Patients With Coronavirus Disease 19 Pneumonia. Gastroenterology 2020;159(1):367-370.

Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, Raizada MK, Grant MB, Oudit GY. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circ Res 2020;126(10):1456-1474.

Wang K, Gheblawi M, Oudit GY. Angiotensin Converting Enzyme 2: A Double-Edged Sword. Circulation. 2020 Aug 4;142(5):426-428.

Gentile S, Strollo F, Mambro A, Ceriello A. COVID-19, ketoacidosis and new-onset diabetes: Are there possible cause and effect relationships among them? Diabetes Obes Metab. 2020 Dec;22(12):2507-2508.

Gu J, Han B, Wang J. COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission. Gastroenterology 2020;158(6):1518-1519.

Hashimoto T, Perlot T, Rehman A, Trichereau J, Ishiguro H, Paolino M, y cols. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012;487(7408):477-81.

Jin X, Lian J, Hu J, Gao J, Zheng L, Zhang Y, y cols. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 2020;69(6):1002-1009.

Song Y, Liu P, Shi XL, Chu YL, Zhang J, Xia J, Gao XZ, Qu T, Wang MY. SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19. Gut. 2020 Jun;69(6):1143-1144.

Launois S, Bizec JL, Whitelaw WA, Cabane J, Derenne JP. Hiccup in adults: an overview. Eur Respir J 1993;6(4):563-75.

Woelk C. Managing hiccups. Can Fam Physician 2011;57(6):672-5, e198-201.

Ferrarese C, Silani V, Priori A, Galimberti S, Agostoni E, Monaco S, Padovani A, Tedeschi G; Italian Society of Neurology (SIN). An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID). Neurol Sci. 2020 Jun;41(6):1355-1359.

Prince G, Sergel M. Persistent hiccups as an atypical presenting complaint of COVID-19. Am J Emerg Med. 2020 Jul;38(7):1546.e5-1546.e6.

Lechien J, Chiesa C, De Siati D, Horoi M, Le Bon S, Rodriguez A, y cols. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261.